Description
BDPARIB Rucaparib 200 Mg Tablets are oral anti-cancer tablets containing Rucaparib 200 Mg. They belong to a class of medicines known as PARP (Poly ADP-Ribose Polymerase) inhibitors and are commonly prescribed for the treatment and management of certain ovarian cancers, fallopian tube cancers, primary peritoneal cancers, and selected prostate cancers under healthcare professional supervision.
Rucaparib is designed to target cancer cells by interfering with DNA repair mechanisms. This action helps prevent cancer cells from repairing damaged DNA, which may support cancer cell death and treatment management as part of targeted oncology care.
Manufactured according to pharmaceutical quality standards, BDPARIB Tablets provide a trusted formulation for oncology treatment support.
Key Highlights
- Contains Rucaparib 200 Mg
- PARP inhibitor anti-cancer medicine
- Commonly used for ovarian and prostate cancer treatment support
- Targeted oncology therapy
- Trusted pharmaceutical formulation
- Convenient oral tablet dosage form
How BDPARIB Rucaparib 200 Mg Tablets Work
Rucaparib works by blocking PARP enzymes involved in repairing damaged DNA within cells. By inhibiting these enzymes, the medicine helps prevent cancer cells from repairing DNA damage, supporting targeted oncology treatment strategies.
Usage Information
- Use only as prescribed by a healthcare professional
- Take the tablet with or without food
- Swallow the tablet whole with water
- Follow the prescribed dosage schedule carefully
- Do not exceed the recommended dosage
Product Information
| Attribute | Details |
|---|---|
| Generic Name | Rucaparib |
| Strength | 200 Mg |
| Form | Oral Tablets |
| Category | Anti-Cancer Medicine |
| Administration | Oral Use |
| Prescription | Required |
Benefits
- Supports targeted oncology treatment plans
- Helps manage specific ovarian cancers
- Supports treatment of certain prostate cancers
- Trusted Rucaparib formulation
- Convenient oral tablet dosage form
Storage Instructions
- Store below 30°C
- Keep in a cool and dry place
- Protect from moisture and direct sunlight
- Keep out of reach of children
- Store in original packaging
Safety Information
- Use only under professional medical supervision
- Follow dosage instructions carefully
- Regular monitoring may be required during treatment
- Inform your healthcare provider about all current medications
- Do not exceed the prescribed dosage
FAQ
What are BDPARIB Rucaparib 200 Mg Tablets used for?
BDPARIB Rucaparib 200 Mg Tablets are commonly used in the treatment and management of certain ovarian cancers, fallopian tube cancers, primary peritoneal cancers, and selected prostate cancers under professional medical guidance.
How do BDPARIB Rucaparib 200 Mg Tablets work?
Rucaparib works by blocking PARP enzymes that help repair damaged DNA in cells. This action helps prevent cancer cells from repairing themselves and supports targeted cancer treatment strategies.
How should BDPARIB Rucaparib 200 Mg Tablets be taken?
They should be taken according to the dosage and schedule prescribed by a healthcare professional. Tablets should be swallowed whole with water and may be taken with or without food.
Is a prescription required for BDPARIB Rucaparib 200 Mg Tablets?
Yes, this medicine should only be used under professional medical supervision and according to prescribed treatment guidelines.
How should BDPARIB Rucaparib 200 Mg Tablets be stored?
Store below 30°C in a cool, dry place away from moisture and direct sunlight. Keep the product in its original packaging and out of reach of children.
There are no reviews yet.